Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)

Stopped Study was terminated for business reasons; not due to safety or efficacy concerns

Conditions

• Agitation
• Dementia

Interventions

• DRUG: BXCL501
• DRUG: Matching Placebo

Sponsor

BioXcel Therapeutics Inc

Collaborators

• [object Object]